Aisling Capital Management LP Verona Pharma PLC Put Options Transaction History
Aisling Capital Management LP
- $243 Million
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding VRNA
# of Institutions
180Shares Held
68.6MCall Options Held
704KPut Options Held
685K-
Perceptive Advisors LLC New York, NY6.32MShares$371 Million4.75% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$328 Million12.27% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.01MShares$294 Million2.01% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx4.22MShares$248 Million2.52% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.55MShares$209 Million14.95% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $3.58B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...